Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gevers

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
European Radiology|May 16, 2016
Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient dataTitus F M Wijnands, Maxime Ronot, Tom J G Gevers, et al.
Gastroenterology|May 14, 2013
Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient dataTom J G Gevers, Joanna Inthout, Anna Caroli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2014
A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney diseaseNiek F Casteleijn, Folkert W Visser, Joost P H Drenth, et al.
European Radiology|January 11, 2018
Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trialTitus F M Wijnands, Tom J G Gevers, Marten A Lantinga, et al.
Hepatology (Baltimore, Md.)|September 19, 2023
Higher need for polycystic liver disease therapy in female patients: Sex-specific association between liver volume and need for therapyThijs R M Barten, Femke Atsma, Adriaan J van der Meer, et al.
The American Journal of Gastroenterology|March 21, 2018
Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic AscitesMyrte Neijenhuis, Tom J G Gevers, Thomas D Atwell, et al.
Journal of Clinical Pharmacology|May 1, 1990
Pharmacokinetics of rimexolone after intra-articular administrationH Derendorf, H Möllmann, G Voortman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2022
Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegalyThijs R M Barten, Roos-Anne M P Bökkerink, Wulphert Venderink, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2013
Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volumeTitus F M Wijnands, Myrte K Neijenhuis, Wietske Kievit, et al.
United European Gastroenterology Journal|August 1, 2025
Non-Adherence to Standard Therapy in Autoimmune Hepatitis: Impact of Steroid Use and Over-the-Counter MedicationsEwa Wunsch, Linda Krause, Ansgar Wilhelm Lohse, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
European Radiology|May 16, 2016
Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient dataTitus F M Wijnands, Maxime Ronot, Tom J G Gevers, et al.
Gastroenterology|May 14, 2013
Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient dataTom J G Gevers, Joanna Inthout, Anna Caroli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2014
A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney diseaseNiek F Casteleijn, Folkert W Visser, Joost P H Drenth, et al.
European Radiology|January 11, 2018
Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trialTitus F M Wijnands, Tom J G Gevers, Marten A Lantinga, et al.
Hepatology (Baltimore, Md.)|September 19, 2023
Higher need for polycystic liver disease therapy in female patients: Sex-specific association between liver volume and need for therapyThijs R M Barten, Femke Atsma, Adriaan J van der Meer, et al.
The American Journal of Gastroenterology|March 21, 2018
Development and Validation of a Patient-Reported Outcome Measurement for Symptom Assessment in Cirrhotic AscitesMyrte Neijenhuis, Tom J G Gevers, Thomas D Atwell, et al.
Journal of Clinical Pharmacology|May 1, 1990
Pharmacokinetics of rimexolone after intra-articular administrationH Derendorf, H Möllmann, G Voortman, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2022
Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegalyThijs R M Barten, Roos-Anne M P Bökkerink, Wulphert Venderink, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 10, 2013
Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volumeTitus F M Wijnands, Myrte K Neijenhuis, Wietske Kievit, et al.
United European Gastroenterology Journal|August 1, 2025
Non-Adherence to Standard Therapy in Autoimmune Hepatitis: Impact of Steroid Use and Over-the-Counter MedicationsEwa Wunsch, Linda Krause, Ansgar Wilhelm Lohse, et al.
Pageof 10